Group One Trading’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31M | Sell |
470,600
-395,300
| -46% | -$25.1M | 0.06% | 320 |
|
|
2025
Q4 | $55M | Sell |
865,900
-299,000
| -26% | -$18.6M | 0.1% | 187 |
|
|
2025
Q3 | $64M | Sell |
1,164,900
-1,641,500
| -58% | -$67.6M | 0.11% | 166 |
|
|
2025
Q2 | $92.7M | Buy |
2,806,400
+1,981,900
| +240% | +$68.9M | 0.21% | 67 |
|
|
2025
Q1 | $33.1M | Buy |
824,500
+466,300
| +130% | +$21.4M | 0.1% | 170 |
|
|
2024
Q4 | $16.8M | Sell |
358,200
-295,600
| -45% | -$15.4M | 0.04% | 448 |
|
|
2024
Q3 | $34.5M | Buy |
653,800
+359,000
| +122% | +$20M | 0.1% | 153 |
|
|
2024
Q2 | $16M | Sell |
294,800
-142,300
| -33% | -$8.59M | 0.06% | 267 |
|
|
2024
Q1 | $30.6M | Sell |
437,100
-750,100
| -63% | -$58M | 0.12% | 117 |
|
|
2023
Q4 | $99.1M | Buy |
1,187,200
+1,119,300
| +1,648% | +$40.5M | 0.26% | 44 |
|
|
2023
Q3 | $2M | Buy |
67,900
+43,200
| +175% | +$1.44M | 0.01% | 1646 |
|
|
2023
Q2 | $806K | Sell |
24,700
-18,800
| -43% | -$696K | ﹤0.01% | 2556 |
|
|
2023
Q1 | $1.53M | Sell |
43,500
-6,400
| -13% | -$261K | 0.01% | 1763 |
|
|
2022
Q4 | $2.29M | Buy |
49,900
+24,300
| +95% | +$1.05M | 0.01% | 1719 |
|
|
2022
Q3 | $1.24M | Sell |
25,600
-12,700
| -33% | -$611K | ﹤0.01% | 2340 |
|
|
2022
Q2 | $1.5M | Buy |
38,300
+21,700
| +131% | +$874K | ﹤0.01% | 2322 |
|
|
2022
Q1 | $611K | Sell |
16,600
-15,000
| -47% | -$533K | ﹤0.01% | 3603 |
|
|
2021
Q4 | $1.44M | Buy |
31,600
+1,700
| +6% | +$65.6K | ﹤0.01% | 2957 |
|
|
2021
Q3 | $1.07M | Buy |
29,900
+29,100
| +3,638% | +$857K | ﹤0.01% | 3341 |
|
|
2021
Q2 | $16K | Sell |
800
-30,600
| -97% | -$718K | ﹤0.01% | 7312 |
|
|
2021
Q1 | $730K | Sell |
31,400
-43,400
| -58% | -$927K | ﹤0.01% | 3598 |
|
|
2020
Q4 | $1.55M | Sell |
74,800
-26,600
| -26% | -$486K | ﹤0.01% | 2255 |
|
|
2020
Q3 | $2.19M | Buy |
101,400
+52,200
| +106% | +$1.22M | 0.01% | 1524 |
|
|
2020
Q2 | $1.16M | Sell |
49,200
-177,800
| -78% | -$3.33M | 0.01% | 1893 |
|
|
2020
Q1 | $2.68M | Buy |
227,000
+148,500
| +189% | +$1.89M | 0.02% | 857 |
|
|
2019
Q4 | $833K | Buy |
78,500
+63,600
| +427% | +$653K | 0.01% | 2039 |
|
|
2019
Q3 | $170K | Sell |
14,900
-3,100
| -17% | -$38.9K | ﹤0.01% | 3200 |
|
|
2019
Q2 | $203K | Buy |
18,000
+4,000
| +29% | +$38.6K | ﹤0.01% | 2840 |
|
|
2019
Q1 | $113K | Sell |
14,000
-2,200
| -14% | -$16.2K | ﹤0.01% | 3089 |
|
|
2018
Q4 | $102K | Sell |
16,200
-4,100
| -20% | -$30.1K | ﹤0.01% | 3140 |
|
|
2018
Q3 | $200K | Buy |
20,300
+17,000
| +515% | +$136K | ﹤0.01% | 3006 |
|
|
2018
Q2 | $27K | Sell |
3,300
-28,200
| -90% | -$235K | ﹤0.01% | 4247 |
|
|
2018
Q1 | $227K | Sell |
31,500
-15,100
| -32% | -$129K | ﹤0.01% | 2691 |
|
|
2017
Q4 | $380K | Buy |
46,600
+34,100
| +273% | +$387K | ﹤0.01% | 2476 |
|
|
2017
Q3 | $181K | Sell |
12,500
-12,800
| -51% | -$175K | ﹤0.01% | 2831 |
|
|
2017
Q2 | $306K | Sell |
25,300
-19,000
| -43% | -$264K | ﹤0.01% | 2331 |
|
|
2017
Q1 | $569K | Buy |
44,300
+30,700
| +226% | +$359K | 0.01% | 1765 |
|
|
2016
Q4 | $165K | Sell |
13,600
-158,000
| -92% | -$1.68M | ﹤0.01% | 2552 |
|
|
2016
Q3 | $1.57M | Buy |
171,600
+132,800
| +342% | +$1.39M | 0.02% | 974 |
|
|
2016
Q2 | $368K | Sell |
38,800
-13,900
| -26% | -$114K | ﹤0.01% | 1952 |
|
|
2016
Q1 | $372K | Buy |
52,700
+25,500
| +94% | +$186K | 0.01% | 1903 |
|
|
2015
Q4 | $285K | Buy |
27,200
+1,300
| +5% | +$12.8K | ﹤0.01% | 2236 |
|
|
2015
Q3 | $173K | Sell |
25,900
-30,500
| -54% | -$208K | ﹤0.01% | 2612 |
|
|
2015
Q2 | $379K | Sell |
56,400
-2,900
| -5% | -$19K | 0.01% | 2013 |
|
|
2015
Q1 | $402K | Buy |
59,300
+7,400
| +14% | +$55.3K | 0.01% | 1792 |
|
|
2014
Q4 | $416K | Buy |
51,900
+16,800
| +48% | +$72.1K | 0.01% | 1691 |
|
|
2014
Q3 | $124K | Sell |
35,100
-58,800
| -63% | -$247K | ﹤0.01% | 2806 |
|
|
2014
Q2 | $449K | Buy |
93,900
+57,100
| +155% | +$348K | 0.01% | 1727 |
|
|
2014
Q1 | $350K | Buy |
36,800
+24,800
| +207% | +$224K | 0.01% | 1946 |
|
|
2013
Q4 | $78K | Buy |
+12,000
| New | +$78.8K | ﹤0.01% | 3256 |
|
Other funds holding CYTK
VPM
VCM
ACA
Group One Trading's CYTK Position: Q1 2026 in Review
Group One Trading reduced its Cytokinetics (CYTK) stake by 11% in Q1 2026, selling an estimated $2.75M and leaving 363,997 shares worth $24M. The position accounts for 0.05% of the portfolio, ranked #405.
Group One Trading first reported a position in CYTK in Q4 2013 and has held it in 36 quarters since. The position peaked at $25.9M in Q4 2025. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.
- Group One Trading held 363,997 shares of Cytokinetics worth $24M as of Q1 2026.
- Group One Trading sold 43,256 Cytokinetics shares in Q1 2026, an estimated $2.75M.
- Cytokinetics made up 0.05% of Group One Trading's portfolio in Q1 2026, its #405 holding.
- Group One Trading first reported a position in Cytokinetics in Q4 2013 and has held it in 36 quarters since.
- Group One Trading's Cytokinetics position peaked at $25.9M in Q4 2025.
- 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.